Journal on Recent Advances in Pain

Register      Login

VOLUME 2 , ISSUE 2 ( May-August, 2016 ) > List of Articles


Anesthesia in Awake Craniotomy: Advantages of Dexmedetomidine Infusion over Conventional Methods

Surjya K Mohanty, Sanjay Banakal, L Channakeshava

Citation Information : Mohanty SK, Banakal S, Channakeshava L. Anesthesia in Awake Craniotomy: Advantages of Dexmedetomidine Infusion over Conventional Methods. J Recent Adv Pain 2016; 2 (2):65-68.

DOI: 10.5005/jp-journals-10046-0044

Published Online: 01-09-2014

Copyright Statement:  Copyright © 2016; The Author(s).



Dexmedetomidine, an a 2 agonist used as infusion with scalp block, is a good adjuvant with analgesic, anxiolytic, and sedative effect with minimal effects on hemodynamic changes and respiration depression. In this study, we report the efficacy of dexmeditomidine for awake craniotomy.

Materials and methods

Three American Society of Anesthesiologists grade 2 patients were posted for tumor resection under awake craniotomy. Scalp block was given with local anesthetic and dexmedetomidine bolus dose of 1 μg/kg/hr followed by 0.2 to 0.4 μg/kg/hr. The patient's speech was monitored by oral questionnaire, motor strength by hand squeezing, and sedation by modified Ramsay Hunt Score.


Bolus dose of 1 μg/kg over 20 minutes infusion of 0.2 to 0.4 μg/kg/hr is a good adjuvant with scalp block with minimal hemodynamic changes.


Dexmedetomidine is a useful adjuvant during awake craniotomy for tumor resection. It has minimal effect on hemodynamics and respiratory system. It can be used in procedures where cooperation of the patient is required intraoperatively.

How to cite this article

Naik SS, Kumar L, Mohanty SK, Banakal S, Channakeshava L. Anesthesia in Awake Craniotomy: Advantages of Dexmedetomidine Infusion over Conventional Methods. J Recent Adv Pain 2016;2(2):65-68.

PDF Share
  1. The laryngeal mask airway for awake craniotomy in the pediatric patient: report of three cases. J Clin Anesth 2004 Feb;16(1):43-47.
  2. Awake craniotomy for removal of intracranial tumor: considerations for early discharge. Anesth Analg 2001 Jan;92(1):89-94.
  3. Day surgery awake craniotomy for removing brain tumors: technical note describing a simple protocol. Minim Invasive Neurosurg 2008 Aug;51(4):208-210.
  4. Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article. J Neurosurg 2011 Mar;114(3):566-573.
  5. Awake mapping optimizes the extent of resection for low-grade gliomas in eloquent areas. Neurosurgery 2010 Jun;66(6):1074-1084.
  6. Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol 2005 Feb;63(2):114-116.
  7. Dexmedetomidine attenuates the hemodynamic and neuroendocrinal responses to skull-pin head-holder application during craniotomy. J Neurosurg Anesthesiol 2008 Jul;20(3):174-179.
  8. Patients’ perceptions of awake and outpatient craniotomy for brain tumor: a qualitative study. J Neurosurg 2010 May;112(5):1056-1060.
  9. Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008 Apr;62(4):753-764; discussion 264-266.
  10. Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors. J Neurosurg 2007 Jul;107(1):1-6.
  11. Dexmedetomidine in awake craniotomy: a technical note. Surg Neurol 2005 Feb;63(2):114-116; discussion 116-117.
  12. Anaesthetic management of awake craniotomy. Ann Fr Anesth Reanim 2004 Apr;23(4):389-394.
  13. Awake neurosurgery: an update. Minerva Anestesiol 2008 Jun;74(6):289-292.
  14. Management of anesthesia in awake craniotomy. Minerva Anestesiol 2008 Jul-Aug;74(7-8):393-408.
  15. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anaesthesiol 2004;16(1):20-25.
  16. Anesthetic approach to high-risk patients and prolonged awake craniotomy using dexmedetomidine and scalp block. J Neurosurg Anesthesiol 2014 Jul;26(3):226-233.
  17. Dexmedetomidine infusion for awake craniotomy. Eur J Anaesthesiol 2005;22:1-2.
  18. Systemic toxicity and resuscitation in bupivacaine-, levobupivacaine-, or ropivacaine-infused rats. Anesth Analg 2001 Sep;93(3):743-748.
  19. Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989 Nov;69(5):563-569.
  20. Electroencephalography for epilepsy surgery. Int Anesthesiol Clin 1990 Summer;28(3):139-142.
  21. The effect of sevoflurane and isoflurane anesthesia on interictal spike activity among patients with refractory epilepsy. Anesth Analg 1999 Nov;89(5):1275-1281.
  22. Seizure surgery: general considerations and specific problems associated with awake craniotomy. Anaesthesiol Clin North Am 1997;15:655-672.
  23. Anaesthesia for awake craniotomy – evolution of a technique that facilitates awake neurological testing. Br J Anaesth 2003;90(2):161-165.
  24. Anaesthetic management of awake craniotomy for tumor resection. Ann Acad Med Singapore 2007 May;36(5):319-325.
  25. Neurosurgical anesthesia. In: Miller RD, editor. Miller's anesthesia. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005. p. 2159-2161.
  26. Clonidine premedication decreases hemodynamic responses to pin head-holder application during craniotomy. Anesth Analg 1998 May;86(5):1001-1004.
  27. The a2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003 Feb;98(2):428-436.
  28. Anaesthesia for awake craniotomy: a retrospective study. Neurol India 2007 Oct-Dec;55(4):376-381.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.